enGene Holdings Inc.
ENGN · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 50% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -3,008.5% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | -3,187.3% |
| EPS Diluted | -0.57 | 0.51 | -0.48 | -0.34 |
| % Growth | -211.8% | 206.3% | -41.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |